- Home
- ACIU vs BVFL Comparison
ACIU vs BVFL Comparison
Compare ACIU & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | BVFL |
|---|---|---|
| Founded | 2003 | 1873 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 172.7M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | BVFL |
|---|---|---|
| Price | $2.97 | $19.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 280.1K | 14.3K |
| Earning Date | 03-12-2026 | 01-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.19 |
| EPS | N/A | ★ 1.43 |
| Revenue | $5,482,957.00 | ★ $42,050,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $495.67 | N/A |
| P/E Ratio | ★ N/A | $13.64 |
| Revenue Growth | N/A | ★ 10.94 |
| 52 Week Low | $1.43 | $13.53 |
| 52 Week High | $4.00 | $19.88 |
Technical Indicators
Market Signals| Indicator | ACIU | BVFL |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 59.30 |
| Support Level | $2.95 | $19.36 |
| Resistance Level | $3.19 | $19.82 |
| Average True Range (ATR) | 0.19 | 0.30 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 15.49 | 73.38 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.